Advanced MRI Measures of Repair in Alemtuzumab Treated Patients (iCAMMS-IST)
This study is enrolling participants by invitation only.
Sponsor:
University of British Columbia
Collaborator:
Genzyme
Information provided by (Responsible Party):
University of British Columbia
ClinicalTrials.gov Identifier:
NCT01307332
First received: January 26, 2011
Last updated: January 16, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | February 2018 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |